GlassScriptPhysician profile
Bethany Blacketer
NPI 1487764833
$1,351.09
in general payments reported to CMS, 2019-2025
18 companies · $425 in 2025
The $425 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $414 · 2020: $242 · 2021: $23.17 · 2023: $15.39 · 2024: $231 · 2025: $425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $671.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $671.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $319.67 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Genzyme Corporation | $158.59 | 2025 | |
| Pfizer INC. | $145.18 | 2019-2025 | |
| Novo Nordisk INC | $138.42 | 2019-2025 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $136.54 | 2019-2020 | |
| Lilly USA, LLC | $109.34 | 2019-2025 | Jardiance |
| Dexcom, INC. | $100.83 | 2019 | |
| Exact Sciences Corporation | $34.96 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Amgen INC. | $29.41 | 2024 | Evenity, Prolia |
| Merck Sharp & Dohme LLC | $27.39 | 2019 | |
| Amarin Pharma, INC. | $26.51 | 2019-2020 | |
| Gilead Sciences, INC. | $21.66 | 2025 | |
| Mylan Specialty L.P. | $21.65 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.33 | 2025 | |
| Janssen Pharmaceuticals, INC | $17.32 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.57 | 2024 | Xifaxan |
| Bioventus LLC | $15.22 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $13.50 | 2025 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bethany Blacketer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.